Using immunohistochemical staining (IHC) and semi-automated scoring, we studied the expression of PcG proteins EZH2, BMI1 and SUZ12 and their associated histone modification H3K27me3 in a cohort of 247 TNM stage I-III colorectal cancer patients, in correlation with clinical outcome. The gene discussed is SUZ12; the disease is colorectal cancer.